Myelodysplastic syndromes may have an infectious etiology

Journal of Toxicology and Environmental Health - Part A

Volumn 61, Issue 5-6, 2000, Pages 387-390

  Raza, Azra ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL CYCLE; CHRONIC INFLAMMATION; CLONOGENESIS; CONFERENCE PAPER; CYTOPENIA; HEMATOPOIESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION; MYELODYSPLASTIC SYNDROME; PALLIATIVE THERAPY; PRIORITY JOURNAL; VIRUS CARCINOGENESIS;

ANIMALS; HEMATOPOIETIC STEM CELLS; HUMANS; MYELODYSPLASTIC SYNDROMES;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0033784526     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/00984100050166406     Document Type: Article

References (11)

1. Mundle, S. D., Venugopal, P., Pandav, D. V., Broady-Robinson, L., Gezer, S., Robin, E. L., Rifkin, S. R., Klein, M., Alston, D. E., Hernandez, B. M., Rosi, D., Alvi, S., Shetty, V. T., Gregory, S. A., and Raza, A. 1996. Indication of an involvement of interleukin 1-P converting enzyme (ICE)-like protease in intramedullary apoptotic cell death in the bone marrows of patients with myelodys-plastic syndromes (MDS). Blood 88(7):2640-2647.
2. Raza, A. 1998. Hypothesis: Myelodysplastic syndromes may have a viral etiology. Int. J. Hematol. 68:245-256.
3. Raza, A. 2000. Consilence across evolving dysplasias affecting myeloid, cervical, esophageal, gastric and liver cells: Common themes and emerging patterns. Leuk. Res. 24:63-72.
4. Raza, A., Gezer, S., Mundle, S., Gao, X.-Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S., and Preisler, H. 1995. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86(1):268-276.
5. Raza, A., Gregory, S. A., and Preisler, H. D. 1996. The myelodysplastic syndromes in 1996: Complex stem cell disorders confounded by dual actions of cytokines. Leuk. Res. 20(11/12):881-890.
6. Raza, A., Alvi, S., Broady-Robinson, L., Showel, M., Cartlidge, J., Mundle, S. D., Shetty, V., Borok, R. Z., Dar, S. E., Chopra, H. K., Span, L., Parcharidou, A., Hines, C., Gezer, S., Venugopal, P., Loew, J., Showel, J., Alston, D., Hernandez, B., Rifkin, S., Robin, E., Shah, R., and Gregory, S. 1997. Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous i odo-and/or bromodeoxyuridine. Exp. Hematol. 25:530-535.
7. Raza, A., Allampallam, K., Shetty, V., Mundle, S., Borok, R., Lisak, L., Andrews, C., Ekbal, M., Mazzoran, L., Zorat, F., Henderson, B., Dangerfield, B., Ansaarie, I., Hussaini, S., Broady-Robinson, L., and Venugopal, P. 1999a. Biologic and clinical response to recombinant human soluble tumor necrosis factor receptor (Enbrel) in patients with myelodysplastic syndromes (MDS). Proc. Am. Soc. Hematol. Blood 94(10):171b, abstr. 39-41.
8. Raza, A., Lisak, L., Andrews, C., Little, L., Muzammil, M., Alvi, S., Mazzoran, L., Zorat, F., Akber, A., Ekbal, M., Razvi, S., and Venugopal, P. 1999b. Thalidomide produces transfusion independence in patients with long-standing refractory anemias and myelodysplastic syndromes (MDS). Proc. Am. Soc. Hematol. Blood 94(10):661a, abstr. 29-35.
9. Raza, A., Qawi, H., Lisak, L., Andric, T., Dar, S., Andrews, C., Venugopal, P., Gezer, S., Gregory, S., Loew, J., Robin, E., Rifkin, S., Hsu, W.-T., and Huang, R.-W. 2000. Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone. Blood 95(5):1580-1587.
10. Reza, S., Shetty, V., Dar, S., Qawi, H., and Raza, A. 1998. Tumor necrosis factor alpha levels decrease with anti-cytokine t herapy in patients with myelodysplastic syndromes. J. Interferon Cytokine Res. 18(10):871-877.
11. Shetty, V., Mundle, S., Alvi, S., Showel, M., Broady-Robinson, L., Dar, S., Borok, R., Showel, J., Gregory, S., Rifkin, S., Gezer, S., Parcharidou, A., Venugopal, P., Shah, R., Hernandez, B., Klein, M., Alston, D., Robin, E., Dominquez, C., and Raza, A. 1996. Measurement of apopto-sis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk. Res. 20(11/12):891-900.